|
Mechanismfibrin modulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date02 Apr 2021 |
100 Clinical Results associated with Shanghai Likangrui Biological Engineering Co., Ltd.
0 Patents (Medical) associated with Shanghai Likangrui Biological Engineering Co., Ltd.
100 Deals associated with Shanghai Likangrui Biological Engineering Co., Ltd.
100 Translational Medicine associated with Shanghai Likangrui Biological Engineering Co., Ltd.